Cancers, Free Full-Text

Neuroblastoma is the most common extracranial solid pediatric tumor, with around 15% childhood cancer-related mortality. High-risk neuroblastomas exhibit a range of genetic, morphological, and clinical heterogeneities, which add complexity to diagnosis and treatment with existing modalities. Identification of novel therapies is a high priority in high-risk neuroblastoma, and the combination of genetic analysis with increased mechanistic understanding—including identification of key signaling and developmental events—provides optimism for the future. This focused review highlights several recent findings concerning chromosomes 1p, 2p, and 11q, which link genetic aberrations with aberrant molecular signaling output. These novel molecular insights contribute important knowledge towards more effective treatment strategies for neuroblastoma.

The Hallmarks of Cancer: Cell

The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet

Cancers, Free Full-Text

Breast Cancer Awareness Month - National Breast Cancer Foundation

Remission, cancer-free, no evidence of disease: What's the difference?

Cancer-Free with Food: A Step-by-Step by Werner Gray, Liana

The role of free-fatty acid receptor-4 (FFA4) in human cancers and cancer cell lines - ScienceDirect

PDF) Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: A single center experience

Cancer free hi-res stock photography and images - Alamy